✦ LIBER ✦

The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b

✍ Scribed by J Brettschneider; D Ecker; A Bitsch; D Bahner; T Bogumil; A Dressel; E Elitok; B Kitze; S Poser; F Weber; H Tumani

Book ID: 114137788
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 97 KB
Volume: 133
Category: Article
ISSN: 0165-5728
DOI: 10.1016/s0165-5728(02)00353-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A macrophage marker, siglec-1, is increa

A macrophage marker, siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type i interferons and toll-like receptor agonists

✍ Michael R. York; Taro Nagai; Alyson J. Mangini; Raphaël Lemaire; Jean Maguire va 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 811 KB

## Abstract ## Objective Microarray analyses of peripheral blood leukocytes have shown that patients with systemic lupus erythematosus express increased levels of type I interferon (IFN)–regulated genes. In this study we examined gene expression by peripheral blood mononuclear cells (PBMCs) from p

PND15 COST-UTILITY OF INTERFERON BETA-1B

PND15 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS

✍ JP Caloyeras; C Wang; L Bauer; WC Lee; V Lanius; K Gondek 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Long-term favorable response to interfer

Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis

✍ Feng-Jun Mei; Manabu Osoegawa; Hirofumi Ochi; Motozumi Minohara; Shi Nan; Hiroyu 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 167 KB

PND26 COST-UTILITY OF INTERFERON BETA-1B

PND26 COST-UTILITY OF INTERFERON BETA-1B IN THE TREATMENT OF PATIENTS WITH A CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS IN SPAIN

✍ T Arbizu; C Piñol; V Casado 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

A case study on the effect of neutralizi

A case study on the effect of neutralizing antibodies to interferon beta 1b in multiple sclerosis patients followed for 3 years with monthly imaging

✍ A. W. Chiu; M. Ehrmantraut; N. D. Richert; V. N. Ikonomidou; S. Pellegrini; H. F 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

Induction of serum soluble tumor necrosi

Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis

✍ M. Comabella; E. Julià; M. Tintoré; L. Brieva; N. Téllez; J. Río; C. López; A. R 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 229 KB